Management of lipid disorders in patients living with HIV.

Management of lipid disorders in patients living with HIV.

Item
http://www.wikidata.org/entity/Q38344129
Hepatitis B virus inhibits apolipoprotein A5 expression through its core geneInteraction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation.Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications.Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).Evidence-based review of statin use in patients with HIV on antiretroviral therapy.Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.Continued Interest and Controversy: Vitamin D in HIV.
P2860

Management of lipid disorders in patients living with HIV.

Item
http://www.wikidata.org/entity/Q38344129
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of lipid disorders in patients living with HIV.
@en
type
label
Management of lipid disorders in patients living with HIV.
@en
prefLabel
Management of lipid disorders in patients living with HIV.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Management of lipid disorders in patients living with HIV.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698